When Singapore entered into Phase Three of the country’s safe-reopening at the start of 2021, public sentiment with regards to the pandemic somewhat eased as the situation appeared to be improving. This is likely to have supported the trend of patients who were suffering from mild symptoms, even if those symptoms were linked to COVID-19, delaying visits to medical clinics and instead preferring to monitor conditions at home first. This behaviour was typical amongst many local consumers prior to...

Euromonitor International’s Analgesics in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.